Globus Medical, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GMED research report →
Companywww.globusmedical.com
Globus Medical, Inc. , a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives.
- CEO
- Keith W. Pfeil
- IPO
- 2012
- Employees
- 5,300
- HQ
- Audubon, PA, US
Price Chart
Valuation
- Market Cap
- $11.33B
- P/E
- 19.39
- P/S
- 3.65
- P/B
- 2.40
- EV/EBITDA
- 12.28
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 67.86%
- Op Margin
- 17.62%
- Net Margin
- 18.92%
- ROE
- 13.04%
- ROIC
- 9.72%
Growth & Income
- Revenue
- $2.94B · 16.65%
- Net Income
- $537.90M · 422.31%
- EPS
- $3.98 · 423.68%
- Op Income
- $479.80M
- FCF YoY
- 45.30%
Performance & Tape
- 52W High
- $101.40
- 52W Low
- $51.79
- 50D MA
- $87.56
- 200D MA
- $78.69
- Beta
- 1.00
- Avg Volume
- 1.28M
Get TickerSpark's AI analysis on GMED
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Feb 25, 26 | Huller Kelly | other | 20,000 |
| Feb 25, 26 | Huller Kelly | other | 20,000 |
| Feb 25, 26 | Huller Kelly | sell | 20,000 |
| Feb 12, 26 | Huller Kelly | other | 10,000 |
| Feb 12, 26 | Huller Kelly | sell | 10,000 |
| Feb 12, 26 | Huller Kelly | other | 10,000 |
| Jan 21, 26 | Norwalk Leslie V | other | 15,000 |
| Jan 21, 26 | Pfeil Keith W | other | 100,000 |
| Jan 21, 26 | Kline Kyle | other | 30,000 |
| Jan 21, 26 | Paul David C | other | 100,000 |
Our GMED Coverage
We haven't published any research on GMED yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate GMED Report →